Clinical & Diagnostic

Vertex Gets Positive CHMP Opinion for First CRISPR Gene Therapy, CASGEVY™, for Sickle Cell Disease

 - If approved by the European Commission, patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thal...

 December 15, 2023 | News

Singapore Introduces New Treatment for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation

Pierre Fabre Singapore receives approval from the Ministry of Health  (“MOH”), Singapore, for the listing of BRAFTOVI on the Cancer Drug L...

 December 15, 2023 | News

Crown Aesthetics Reveals Groundbreaking Study on BIOJUVE™ Skin Microbiome-Optimized Regimen

Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced  that its groundbreaking clinical study, recently accepted for publication i...

 December 14, 2023 | News

Virtual twin to improve treatment with cancer immunotherapies

In recent years, cancer immunotherapies have established themselves as a further pillar of medical oncology alongside traditional treatment options (surger...

 December 14, 2023 | News

Inside the World of Cell Therapies: Illuminating the Future of Cancer Care

The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...

 December 13, 2023 | News

First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging

The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...

 December 12, 2023 | News

CSL Behring's HEMGENIX® Shows Long-Term Durability and Safety in Hemophilia B

HEMGENIX® is the first and only gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of he...

 December 12, 2023 | News

Thermo Fisher Unveils Automated Solutions for Respiratory Testing

New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories. ...

 December 12, 2023 | News

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

The Rare Disease Diagnosis and Intractable Disease Research Center at Juntendo University has improved its diagnostic capabilities by combining research ...

 December 11, 2023 | News

Sirnaomics Successfully Completes Phase I Study for Anticoagulant RNAi Therapeutic STP122G

Cohort 1 is comprised of eight subjects who completed dosing and were followed over a period of 140 days. Safety data showed there were no dose-limiting to...

 December 06, 2023 | News

Addressing the Dengue Crisis in Southeast Asia: Insights from Prof. Tikki Pangestu and Prof. Lulu Bravo

In this exclusive interview, BioPharma APAC engage with two distinguished experts in the field of infectious diseases and immunization: Prof. Tikki Pangest...

 December 04, 2023 | News

Thermo Fisher and Project HOPE Collaborate for Health Equity in Sub-Saharan Africa's HIV-Positive Youth.

 Thermo Fisher Scientific Inc., the world leader in serving science, and Project HOPE, a leading global health and humanitarian organization, tod...

 December 04, 2023 | News

China Pharma Completes Third-Party Testing for Dry Eye Therapeutic Device

According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...

 November 30, 2023 | News

AbbVie Provides FDA and EMA Updates on Epcoritamab for Lymphoma Treatment

Updates are supported by data from the Phase 1/2 EPCORE™ NHL-1 clinical trial AbbVie  announced updates from the U...

 November 29, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close